Previous Next

News Releases    Health & Medical

Translations: 


Health & Medical Results: 1879 item(s)
MUMBAI, Nov. 23, 2020 /PRNewswire-AsiaNet/ -- Cipla signed a licensing agreement with MultiG for COVID-19 rapid antibody test kit Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it signed a licensing agreement with a Belgium-...
DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire-AsiaNet/-- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowledged through a letter ...
TEL AVIV, Israel and RALEIGH, N.C., November 20, 2020, /PRNewswire-AsiaNet/-- RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy The Phase 3 study is expected to recruit up to 125 patien...
PLYMOUTH MEETING, Pennsylvania Nov. 20, 2020 /PRNewswire-AsiaNet/ -- -- Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely...
TOKYO and HYDERABAD, India, Nov. 17 /PRNewswire-AsiaNet/-- - Participating in the PharmaLab Expo Tokyo during Nov 25-27 to jumpstart outreach Sai Life Sciences, one of India's fastest growing Contract Research, Development & Manufacturing Organizations [https://www.sailife.com/?utm_source=pr&utm_me...
TEL AVIV, Israel and RALEIGH, N.C., Nov. 17, 2020 /PRNewswire-AsiaNet/ -- FDA clears IND application for Phase 2/3 study with RedHill's second novel COVID-19 candidate, RHB-107 (upamostat), an orally administered novel serine protease inhibitor, with demonstrated antiviral and potential tissue-protective effects The ...
TEL AVIV, Israel and RALEIGH, NC, Nov. 20, 2020 /PRNewswire-AsiaNet/ -- Enrollment completed in the U.S. Phase 2 study evaluating opaganib's safety and initial efficacy signal in 40 hospitalized patients with severe COVID-19 pneumonia A parallel global Phase 2/3 study with orally administered opaganib for severe CO...
CLEVELAND, Nov. 20, 2020 /PRNewswire-AsiaNet/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) prog...
UDINE, Italy, Nov. 20, 2020 /PRNewswire-AsiaNet/ -- LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) to start the clinical trial of the SMR Stemless Reverse Shoulder System. Logo - https://mma.prnewswire.c...
SAN FRANCISCO and ANN ARBOR, Mich., Nov. 19, 2020 /PRNewswire-AsiaNet/ -- endpoint Clinical ( https://c212.net/c/link/?t=0&l=en&o=2986884-1&h=3561717008&u=https%3A%2F%2Fwww.endpointclinical.com%2Firt-solution%2F&a=endpoint+Clinical ), the leading global interactive response technology (IRT(R)) company, and McCreadie Gro...

Previous Page Page 9 of 188 Next Page ...  4  5  6  7  8  9  10  11  12  13  ... Go to page Go